Home / People / Gertie Lintjens
Portrait ofGertie Lintjens

Gertie Lintjens

Of Counsel

Contact
CMS Derks Star Busmann
Atrium - Parnassusweg 737
1077 DG Amsterdam
PO Box 94700
1090 GS Amsterdam
Netherlands
Languages Dutch, English, German

Gertie Lintjens is a Life Sciences expert who has gained almost 20 years of experience working as in-house counsel, predominately in the Life Sciences industry. After being appointed a judge trainee in 1996, she has pursued her career in 1998 as an in-house counsel. She held senior international legal positions in global companies like Heinz and Eli Lilly and has been general counsel of myTomorrows, an online platform that enables access to drugs in development.​

Based on her unique insight into the Life Sciences industry she advises clients that are active in the field of pharmaceuticals and medical devices on a broad range of legal and compliance matters, including advertising and promotion, pricing and reimbursement, early access schemes, clinical research, patient programs, product launches, late life cycle management and investigations of health care authorities. She is also very experienced in reviewing, drafting and negotiating industry related commercial contracts like manufacturing, supply and distribution, wholesale, co-promoting and co-marketing. Gertie also advices on compliance matters related to the Life Sciences industry, often linked to code of conducts and standard operating procedures on anti-corruption and anti-bribery and the industry's self-regulation on its interactions with health care professionals.

more less

‘Her ability to deep dive into details and find a solution is a gift’.

The Legal500 EMEA, 2022

Really great to work with, very approachable, pragmatic, high quality that is spot on even in complex situations.

The Legal 500 EMEA, 2021

Very knowledgeable within medical devices industry.

The Legal 500 EMEA, 2021

‘Ellen Gielen and Gertie Lintjens have helped us navigate some complicated challenges in a clear and practical way.’

The Legal 500 EMEA, 2020

Memberships & Roles

  • Dutch pharmaceutical law association
more less

Awards & Rankings

  • The Legal 500 EMEA, 2023, Gertie Lintjens is ranked Next Generation Partners 
  • The Legal 500 EMEA, 2023, Gertie Lintjens is Recommended
more less

Education

  • Corporate Structures, Grotius Academy for Post-Graduate Law Studies
  • Management and Economics for lawyers, University of Amsterdam
  • Dutch Law (Private and European Law), Maastricht University
  • Law, University of Trier
  • Business Economics (Finance), Tilburg University
more less

Feed

27/03/2024
CMS ranked in the Legal 500 EMEA 2024
The latest rankings of the Legal 500 Europe, Middle East & Africa (EMEA) are out. We would like to thank our clients for their trust in us and their feedback. Our lawyers are described as 'personal...
26/10/2023
Global Life Sciences & Healthcare Forum 2023 – recordings & presentations
We were delighted to bring you this year’s Forum, “Blurring Boundaries - Exploring the convergence of life sciences and law”, from Amsterdam. The theme “Blurring Boundaries - Exploring the convergence of life sciences and law” aimed to:Uncover the latest breakthroughs: Dive into the forefront of life sciences advances, including biotechnology, genetics, pharmaceuticals, and medical devicesAddress the regulatory gap: Engage in interactive workshops to bridge the divide between rapid innovation and the development of legal frame­work­sNav­ig­ate global challenges: Explore the impact of globalisation, ethical considerations, privacy concerns, and societal implications on the life sciences sectorFoster collaboration: Connect with legal and scientific minds, exchange ideas, and build valuable re­la­tion­shipsP­resent­a­tions were delivered by fantastic industry speakers, including Annemiek Verkamman (Managing Director, Hollandbio), Charida Dorder (Member of the Dutch AI Coalition), Wouter Boon (Associate Professor, Utrecht University) and Marc Kaptein (Medical Director, Pfizer), as they shared their expertise, thoughts and insights on how the sector is “Blurring Boundaries”. We were also joined by Simon Neill (Senior Legal Director) at Johnson & John­son and Joep Rijnierse (Senior Medical Director) at Amgen in our workshops. This webpage has been designed to keep you updated on the Forum, our speakers, as well as provide you with the useful resources complementing the theme “Blurring Boundaries - Exploring the convergence of life sciences and law”. You will also find on this page details on how to stay connected with CMS through our upcoming webinar series, On the Pulse Webinar Series 2023 - Autumn (cms. law); free eAlert service, Law-Now; and social media channels.
16/10/2023
Blurring Boundaries – Exploring the convergence of life sciences and law
A unique life sciences Forum brought the legal challenges created by the rapid pace of technological advances into sharp focus with sector focused sessions and informative workshops. Experts from across the sector framed the incredible potential from digital and AI and called for the expertise of legal teams to take the ‘’regulatory handbrake’ off innovation that has transformative potential for healthcare systems and patients. CMS’s much-anticipated Global Life Sciences & Healthcare Forum 2023, co-hosted by Ellen Gielen, Roland Wiring and Gertie Lintjens, delivered a wealth of insight and ignited discussion about how regulatory frameworks can be tested and revised without compromising safety, security and compliance. Blurring Boundaries – Exploring the convergence of life sciences and law heard from leading figures from pharmaceutical companies, cutting edge AI enterprises, legal experts and biotech organisations with a strong accent on debate and collaboration. Marc Kaptein, Medical Director, Pfizer, revealed the unchartered territory he and his team had to tread during the pandemic as the company partnered with BioNTech to release a COVID vaccine and maximise its public uptake. In a fascinating talk, he outlined the twists and turns of the inside story of how Pfizer struck a rapid deal with BioNTech by ‘shaking hands’ and then balanced the societal benefits of maximising its vaccination with legal constraints designed to control public promotion.A willingness to break fresh ground legally, politically, scientifically and logistically was an integral part of the success story and he underlined to guests at the Forum, held in Amsterdam, that ‘without blurring boundaries, we would not have got where we are today’. Joep Rijnierse, Senior Medical Director at Amgen, highlighted its pioneering approach to  work closely with patient groups to generate therapy promise across a complete health condition. He said that the company’s medical departments worked with internal and external legal advisers to find ways to manage constraints in the mission to enhance all areas of healthcare delivery to improve systems and outcomes. Legal expertise is critical in shaping the landscape for AI developments and speakers from across the life sciences spectrum underscored the need for regulatory frameworks to evolve at pace. Life sciences is experiencing seismic change and Thibault Helleputte, the Founder and CEO of DNAlytics, revealed that the BioGPT initiative was able to identify medical hypotheses from deep in the data of 15 million papers in PubMed library to give scientists unprecedented R&D leads. The Forum was an opportunity to discuss how legal teams can use their skill and knowledge to ensure that regulatory frameworks did not impede progress and to explore fast and safe pathways for innovations to become working reality. Wouter Boon, Associate Professor in Innovation and Life Sciences at Utrecht University, emphasised the need to place legal aspects at the inception of the innovation process, observing that the sector was ‘highly regulated for all good reasons but it means that radical innovation has a tough job.’The Forum covered an impressive sweep of themes including AI, digital therapeutics, the challenges of multi-jur­is­dic­tion­al online pharmacies, the new EU medicines directive and co-creation with regulators.“We had a great range of speakers who focused on advances and roadblocks across the life sciences sector and provided us all with some innovative and provocative approaches,” said Nick Beckett, Global Co-Head of CMS Life Sciences & Healthcare Sector Group. “It was a fantastic opportunity to discuss, explore and collaborate and the insights and learnings it generated will help us face global challenges in life sciences.“We have to navigate global challenges such as sustainability, poverty, inequality, ageing populations; concerns about privacy with the use of data, concerns about ethics and the use of AI. To do that we need global perspectives and we believe that CMS as a firm, with 80 offices worldwide, is well positioned to navigate issues, foster collaborations and be a vital partner in moving life science innovation forward in the digital age.”
12/10/2023
Global Life Sciences & Healthcare Forum 2023
Blurring Boundaries - Exploring the convergence of life sciences and law
09/10/2023
Closing the gap between fast-paced technological advances in life sciences...
CMS Life Sciences & Healthcare Sector Group’s Forum 2023 provides expert insights, discussion and innovations to meet the challenge
12/04/2023
CMS ranked in the new Legal 500 EMEA
The latest rankings of the Legal 500 Europe, Middle East & Africa (EMEA) are out. We would like to thank our clients for their trust in us and their feedback. Our lawyers are described as 'personal, professional...
14/04/2021
Top rankings CMS in Legal 500 EMEA 2021
CMS has once again been ranked in the latest edition of The Legal 500 Europe, Middle East & Africa (2021). We thank our clients for putting their trust in us and recognising our expertise. Our lawyers...
15/04/2020
Top rankings CMS in Legal 500 EMEA 2020
The online edition of The Legal 500 Europe, Middle East & Africa (EMEA) 2020 has been published. Our lawyers are described as 'accurate, quick, flexible and knowledgeable'. CMS is valued for its presence...
06/09/2019
Blue Tulip Awards - Health
Healthcare Faces Growing Needs Modern-day society is rapidly expanding, putting pressure on our healthcare systems. Therefore, we need to increase the quality of care while reducing costs. Hospitals, practices, laboratories, and corporations will have to step up to keep up with competition, new technology and patients’ growing needs. Innovations in healthcare can provide unique opportunities to transform our society and keep healthcare effective, accessible and affordable to all.  The intellectual property dilemmas caused by AI-generated works With the rise of artificial intelligence (AI) in many sectors, questions pop up about the full extent of AI use and its influence on ownership and ac­count­ab­il­ity. In healthcare, AI is used to support and advise doctors in establishing a diagnosis, assist radiologists in improving image interpretation, and improve drug discovery research, to name just a few of the current ap­plic­a­tions. How­ever, with the rise of a new technologies, new issues arise too. If we take a look at the last example, an important question that comes up is: who owns what when AI does the research? To answer this question - and offer you advice on how to deal with this regarding your AI innovation - we’ll review patent and copyright law in this context. Read more
11/04/2019
Top rankings CMS in The Legal 500 EMEA 2019
The online edition of The Legal 500 Europe, Middle East & Africa (EMEA) 2019 has been published. Our lawyers are described as pragmatic, class, pleasant and knowledgeable. CMS is valued for its presence...
17/04/2018
CMS rankings in The Legal 500 EMEA 2018
The online edition of The Legal 500 Europe, Middle East & Africa 2018 has been published. CMS is described as 'top-class', 'pragmatic' and 'proven to be reliable and responsive'. Rankings Like last year...